LL-37 (Cathelicidin)
LL-37 5mg Research Peptide (Cathelicidin)
LL-37 is a synthetic 37-amino-acid peptide with the sequence LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES, corresponding to the C-terminal peptide of the human cathelicidin precursor hCAP18. This vial contains 5 mg of lyophilized LL-37, supplied as a reference material for in vitro laboratory research.
Intended for use by qualified researchers in controlled laboratory settings, for example as a reference standard in analytical method development, LC-MS identity work and in vitro assays.
Chemical identity
| Name | LL-37 (human cathelicidin peptide) |
|---|---|
| Synonyms | LL37; hCAP18 (134–170); CAMP-derived peptide |
| Sequence (one-letter) | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
| Length | 37 amino acids, free N-terminus and free C-terminus |
| Residue composition | Lys 6, Arg 5, Leu 4, Phe 4, Glu 3, Ile 3, Gly 2, Asp 2, Ser 2, Val 2, Gln 1, Asn 1, Pro 1, Thr 1 |
| CAS number | 154947-66-7 |
| Molecular formula | C205H340N60O53 |
| Average molecular weight | 4493.3 g/mol |
| Monoisotopic mass | 4490.58 Da |
Product specifications
| Form | Lyophilized powder |
|---|---|
| Appearance | White to off-white solid |
| Vial size | 5 mg per vial (nominal fill; net peptide content depends on salt form and counterion) |
| Storage (lyophilized) | −20 °C in the closed vial, sealed and protected from moisture and light |
| Intended use | In vitro laboratory research only |
Structural notes
LL-37 is a linear 37-residue peptide with no cysteine, so it has no disulfide bonds, and no methionine or tryptophan. It carries 11 basic side chains (6 lysine and 5 arginine) and 5 acidic side chains (2 aspartic acid and 3 glutamic acid), giving a net positive side-chain charge of about +6 at neutral pH, and it has four phenylalanine and four leucine residues. It has a free N-terminal amine and a free C-terminal carboxylic acid.
Analytical identification
Expected masses for identity checks by LC-MS: 4493.3 Da average, 4490.58 Da monoisotopic. The mass shifts if the material is supplied as a salt, and multiply charged ions are expected for a peptide of this size. Researchers should verify identity and purity of each lot with their own RP-HPLC and mass-spectrometry methods. This page does not state a purity figure.
Handling and storage
Keep the lyophilized powder at −20 °C in the original closed vial, sealed and protected from light and moisture. Allow the vial to reach room temperature before opening to limit condensation. Avoid repeated freeze–thaw cycles of any prepared solution, and follow your laboratory’s own procedures.
Research use only
For laboratory research use only. Not for human or veterinary use. Not a drug, food, dietary supplement or cosmetic, and not intended for diagnostic or therapeutic use. Not an FDA-approved drug product. No dosing, reconstitution or usage information for people or animals is provided. Buyers must be qualified researchers and are responsible for compliance with all applicable laws.
Frequently asked questions
What is LL-37?
LL-37 is a synthetic 37-amino-acid peptide, LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES. This product is a research material for in vitro laboratory work.
What is the amino acid sequence of LL-37?
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES, thirty-seven residues, with a free N-terminus and a free C-terminus.
What are the CAS number and molecular weight of LL-37?
CAS 154947-66-7, molecular formula C205H340N60O53, average molecular weight 4493.3 g/mol (monoisotopic 4490.58 Da).
Is LL-37 the same as cathelicidin?
LL-37 is the 37-residue C-terminal peptide of the human cathelicidin precursor hCAP18. The two names are sometimes used loosely, and this product is the 37-residue peptide.
What form and size is this product?
A lyophilized powder with a nominal fill of 5 mg per vial. Net peptide content depends on the salt form and counterion.
How should LL-37 be stored?
At −20 °C in the closed vial, away from light and moisture, and let it reach room temperature before opening.
Do you provide dosing or reconstitution instructions?
No. This product is sold for in vitro laboratory research only, and no dosing, reconstitution or usage instructions are provided.
Is this an approved drug?
No. This product is a research material. It is not an FDA-approved drug, it has not been evaluated by the FDA for any use, and it is sold for in vitro research only.
Can this product be used in people or animals?
No. It is for laboratory research use only and is not for human or veterinary use.
Research Use Disclaimer
Legal Notice
Products provided by Peptide Biogenix are intended exclusively for laboratory research and scientific development. They are not approved for human or veterinary use.
Purchaser Responsibility
By placing an order, you acknowledge responsibility for the lawful handling, storage, and use of all research materials in accordance with applicable regulations.
